iRhythm(US:IRTC) Prnewswireยท2025-06-17 15:00Core Viewpoint - iRhythm Technologies, Inc. is facing legal scrutiny due to allegations of securities fraud related to misleading statements about its Zio AT heart event monitor, which may have inflated stock prices and misled investors [2][3] Group 1: Legal Proceedings - A U.S. District Court judge has allowed a securities fraud lawsuit against iRhythm and its CEO to proceed, claiming that the company misrepresented the accuracy and reliability of its Zio AT monitor from November 2021 to August 2024 [2] - The lawsuit alleges that iRhythm's misleading statements led to inflated stock prices, with insiders selling approximately $18 million worth of stock during this period [2] - The U.S. Department of Justice is also investigating iRhythm's marketing practices in connection with these allegations [2] Group 2: Investor Actions - Schubert Jonckheer & Kolbe LLP is advising iRhythm investors to explore potential legal claims regarding the alleged false statements made by the company [1][4] - Current shareholders are encouraged to contact the law firm to learn about their legal options [4]